- €13.57bn
- €24.54bn
- €56.02bn
- 62
- 88
- 56
- 81
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | — | — | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 37,929 | 34,694 | 37,589 | 44,322 | 56,017 |
Cost of Revenue | |||||
Gross Profit | 20,206 | 19,299 | 20,849 | 25,011 | 30,201 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 36,233 | 33,570 | 35,856 | 42,450 | 53,904 |
Operating Profit | 1,696 | 1,124 | 1,733 | 1,872 | 2,113 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,422 | 871 | 1,515 | 1,585 | 1,689 |
Provision for Income Taxes | |||||
Net Income After Taxes | 970 | 554 | 1,083 | 1,161 | 1,142 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1,184 | 696 | 1,125 | 973 | 1,040 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,184 | 696 | 1,125 | 973 | 1,040 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.18 | 2.45 | 2.79 | 2.64 | 2.98 |
Dividends per Share |